IXP Launches Rs 200 Crore Fund for Lifesciences Innovation

IXP, a lifesciences venture capital firm backed by JV Ventures, has launched its inaugural IXP Lifesciences Catalyst Fund, aiming to raise INR 200 crore to invest in early-stage B2B companies ranging from pre-seed to Series A stages. This fund, which includes a greenshoe option of INR 100 crore, intends to target 20-25 companies focused on innovations in pharmaceuticals, biotechnology, medical technology, specialty chemicals, agrotechnology, and nutraceuticals. The firm emphasizes a hands-on approach, co-creating businesses with scientists and providing access to necessary ecosystems for R&D services, laboratories, and networks through its PoweRx initiative. Ketki Tulpule, CIO at IXP, highlighted the importance of scientific expertise and operational experience in the success of biotech ventures. The fund aims to address unmet market needs while transforming scientists into founders through its Venturepreneur Program. IXP's strategy reflects a commitment to nurturing India's dynamic lifesciences sector, which is seen as having significant untapped potential.